LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 31

Search options

  1. Article: Mechanisms Generating Cancer Genome Complexity: Back to the Future.

    Toledo, Franck

    Cancers

    2020  Volume 12, Issue 12

    Abstract: Understanding the mechanisms underlying cancer genome evolution has been a major goal for decades. A recent study combining live cell imaging and single-cell genome sequencing suggested that interwoven chromosome breakage-fusion-bridge cycles, ... ...

    Abstract Understanding the mechanisms underlying cancer genome evolution has been a major goal for decades. A recent study combining live cell imaging and single-cell genome sequencing suggested that interwoven chromosome breakage-fusion-bridge cycles, micronucleation events and chromothripsis episodes drive cancer genome evolution. Here, I discuss the "interphase breakage model," suggested from prior fluorescent in situ hybridization data that led to a similar conclusion. In this model, the rapid genome evolution observed at early stages of gene amplification was proposed to result from the interweaving of an amplification mechanism (breakage-fusion-bridge cycles) and of a deletion mechanism (micronucleation and stitching of DNA fragments retained in the nucleus).
    Language English
    Publishing date 2020-12-15
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers12123783
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes.

    Rakotopare, Jeanne / Toledo, Franck

    International journal of molecular sciences

    2023  Volume 24, Issue 19

    Abstract: Mice with a constitutive increase in p53 activity exhibited features of dyskeratosis congenita (DC), a bone marrow failure syndrome (BMFS) caused by defective telomere maintenance. Further studies confirmed, in humans and mice, that germline mutations ... ...

    Abstract Mice with a constitutive increase in p53 activity exhibited features of dyskeratosis congenita (DC), a bone marrow failure syndrome (BMFS) caused by defective telomere maintenance. Further studies confirmed, in humans and mice, that germline mutations affecting
    MeSH term(s) Humans ; Animals ; Mice ; Tumor Suppressor Protein p53/genetics ; Bone Marrow Failure Disorders ; Fanconi Anemia/genetics ; Anemia, Diamond-Blackfan/genetics ; Dyskeratosis Congenita/genetics ; Telomere/genetics ; Nuclear Proteins/genetics ; Cell Cycle Proteins/genetics ; Proto-Oncogene Proteins/genetics ; Exodeoxyribonucleases/genetics
    Chemical Substances Tumor Suppressor Protein p53 ; DKC1 protein, human ; Nuclear Proteins ; Cell Cycle Proteins ; MDM4 protein, human ; Proto-Oncogene Proteins ; DCLRE1B protein, human (EC 3.1.-) ; Exodeoxyribonucleases (EC 3.1.-)
    Language English
    Publishing date 2023-10-06
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms241914940
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes

    Jeanne Rakotopare / Franck Toledo

    International Journal of Molecular Sciences, Vol 24, Iss 14940, p

    2023  Volume 14940

    Abstract: Mice with a constitutive increase in p53 activity exhibited features of dyskeratosis congenita (DC), a bone marrow failure syndrome (BMFS) caused by defective telomere maintenance. Further studies confirmed, in humans and mice, that germline mutations ... ...

    Abstract Mice with a constitutive increase in p53 activity exhibited features of dyskeratosis congenita (DC), a bone marrow failure syndrome (BMFS) caused by defective telomere maintenance. Further studies confirmed, in humans and mice, that germline mutations affecting TP53 or its regulator MDM4 may cause short telomeres and alter hematopoiesis, but also revealed features of Diamond–Blackfan anemia (DBA) or Fanconi anemia (FA), two BMFSs, respectively, caused by defects in ribosomal function or DNA repair. p53 downregulates several genes mutated in DC, either by binding to promoter sequences ( DKC1 ) or indirectly via the DREAM repressor complex ( RTEL1 , DCLRE1B ), and the p53-DREAM pathway represses 22 additional telomere-related genes. Interestingly, mutations in any DC-causal gene will cause telomere dysfunction and subsequent p53 activation to further promote the repression of p53-DREAM targets. Similarly, ribosomal dysfunction and DNA lesions cause p53 activation, and p53-DREAM targets include the DBA-causal gene TSR2 , at least 9 FA-causal genes, and 38 other genes affecting ribosomes or the FA pathway. Furthermore, patients with BMFSs may exhibit brain abnormalities, and p53-DREAM represses 16 genes mutated in microcephaly or cerebellar hypoplasia. In sum, positive feedback loops and the repertoire of p53-DREAM targets likely contribute to partial phenotypic overlaps between BMFSs of distinct molecular origins.
    Keywords p53 ; DREAM repressor complex ; dyskeratosis congenita ; Fanconi anemia ; Diamond–Blackfan anemia ; microcephaly ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
    Subject code 572
    Language English
    Publishing date 2023-10-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: p53: A two-faced regulator of telomere metabolism? (comment on DOI 10.1002/bies.201600078).

    Toledo, Franck

    BioEssays : news and reviews in molecular, cellular and developmental biology

    2016  Volume 38, Issue 10, Page(s) 938

    Language English
    Publishing date 2016-10
    Publishing country United States
    Document type Journal Article
    ZDB-ID 50140-2
    ISSN 1521-1878 ; 0265-9247
    ISSN (online) 1521-1878
    ISSN 0265-9247
    DOI 10.1002/bies.201600149
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities

    Jeanne Rakotopare / Vincent Lejour / Carla Duval / Eliana Eldawra / Hugues Escoffier / Franck Toledo

    Disease Models & Mechanisms, Vol 16, Iss

    2023  Volume 10

    Keywords p53 ; dream repressor complex ; bone marrow failure ; microcephaly ; cerebellar hypoplasia ; glioblastoma ; Medicine ; R ; Pathology ; RB1-214
    Language English
    Publishing date 2023-10-01T00:00:00Z
    Publisher The Company of Biologists
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities.

    Rakotopare, Jeanne / Lejour, Vincent / Duval, Carla / Eldawra, Eliana / Escoffier, Hugues / Toledo, Franck

    Disease models & mechanisms

    2023  Volume 16, Issue 10

    Abstract: p53 (encoded by Trp53) is a tumor suppressor, but mouse models have revealed that increased p53 activity may cause bone marrow failure, likely through dimerization partner, RB-like, E2F4/E2F5 and MuvB (DREAM) complex-mediated gene repression. Here, we ... ...

    Abstract p53 (encoded by Trp53) is a tumor suppressor, but mouse models have revealed that increased p53 activity may cause bone marrow failure, likely through dimerization partner, RB-like, E2F4/E2F5 and MuvB (DREAM) complex-mediated gene repression. Here, we designed a systematic approach to identify p53-DREAM pathway targets, the repression of which might contribute to abnormal hematopoiesis. We used Gene Ontology analysis to study transcriptomic changes associated with bone marrow cell differentiation, then chromatin immunoprecipitation-sequencing (ChIP-seq) data to identify DREAM-bound promoters. We next created positional frequency matrices to identify evolutionary conserved sequence elements potentially bound by DREAM. The same approach was developed to find p53-DREAM targets associated with brain abnormalities, also observed in mice with increased p53 activity. Putative DREAM-binding sites were found for 151 candidate target genes, of which 106 are mutated in a blood or brain genetic disorder. Twenty-one DREAM-binding sites were tested and found to impact gene expression in luciferase assays, to notably regulate genes mutated in dyskeratosis congenita (Rtel1), Fanconi anemia (Fanca), Diamond-Blackfan anemia (Tsr2), primary microcephaly [Casc5 (or Knl1), Ncaph and Wdr62] and pontocerebellar hypoplasia (Toe1). These results provide clues on the role of the p53-DREAM pathway in regulating hematopoiesis and brain development, with implications for tumorigenesis.
    MeSH term(s) Animals ; Mice ; Brain/metabolism ; Cell Cycle Proteins/genetics ; Cyclin-Dependent Kinase Inhibitor p21/genetics ; Promoter Regions, Genetic/genetics ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism
    Chemical Substances Cell Cycle Proteins ; Cyclin-Dependent Kinase Inhibitor p21 ; Tumor Suppressor Protein p53
    Language English
    Publishing date 2023-10-11
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2451104-3
    ISSN 1754-8411 ; 1754-8403
    ISSN (online) 1754-8411
    ISSN 1754-8403
    DOI 10.1242/dmm.050376
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: The Guardian of the Genome Revisited: p53 Downregulates Genes Required for Telomere Maintenance, DNA Repair, and Centromere Structure.

    Toufektchan, Eléonore / Toledo, Franck

    Cancers

    2018  Volume 10, Issue 5

    Abstract: The p53 protein has been extensively studied for its capacity to prevent proliferation of cells with a damaged genome. Surprisingly, however, our recent analysis of mice expressing a hyperactive mutant p53 that lacks the C-terminal domain revealed that ... ...

    Abstract The p53 protein has been extensively studied for its capacity to prevent proliferation of cells with a damaged genome. Surprisingly, however, our recent analysis of mice expressing a hyperactive mutant p53 that lacks the C-terminal domain revealed that increased p53 activity may alter genome maintenance. We showed that p53 downregulates genes essential for telomere metabolism, DNA repair, and centromere structure and that a sustained p53 activity leads to phenotypic traits associated with dyskeratosis congenita and Fanconi anemia. This downregulation is largely conserved in human cells, which suggests that our findings could be relevant to better understand processes involved in bone marrow failure as well as aging and tumor suppression.
    Language English
    Publishing date 2018-05-06
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers10050135
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Targeting MDM4 Splicing in Cancers.

    Bardot, Boris / Toledo, Franck

    Genes

    2017  Volume 8, Issue 2

    Abstract: MDM4, an essential negative regulator of the P53 tumor suppressor, is frequently overexpressed in cancer cells that harbor a wild-type P53. By a mechanism based on alternative splicing, the MDM4 gene generates two mutually exclusive isoforms: MDM4-FL, ... ...

    Abstract MDM4, an essential negative regulator of the P53 tumor suppressor, is frequently overexpressed in cancer cells that harbor a wild-type P53. By a mechanism based on alternative splicing, the MDM4 gene generates two mutually exclusive isoforms: MDM4-FL, which encodes the full-length MDM4 protein, and a shorter splice variant called MDM4-S. Previous results suggested that the MDM4-S isoform could be an important driver of tumor development. In this short review, we discuss a recent set of data indicating that MDM4-S is more likely a passenger isoform during tumorigenesis and that targeting MDM4 splicing to prevent MDM4-FL protein expression appears as a promising strategy to reactivate p53 in cancer cells. The benefits and risks associated with this strategy are also discussed.
    Language English
    Publishing date 2017-02-20
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527218-4
    ISSN 2073-4425
    ISSN 2073-4425
    DOI 10.3390/genes8020082
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Mdm4: don't judge an isoform by its mRNA levels!

    Bardot, Boris / Toledo, Franck

    Aging

    2015  Volume 7, Issue 10, Page(s) 744–745

    MeSH term(s) Alternative Splicing ; Animals ; Humans ; Proto-Oncogene Proteins/metabolism ; Tumor Suppressor Protein p53/metabolism ; Ubiquitin-Protein Ligases/metabolism
    Chemical Substances Mdm4 protein, mouse ; Proto-Oncogene Proteins ; Tumor Suppressor Protein p53 ; Ubiquitin-Protein Ligases (EC 2.3.2.27)
    Language English
    Publishing date 2015-10
    Publishing country United States
    Document type Editorial
    ISSN 1945-4589
    ISSN (online) 1945-4589
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Les liaisons dangereuses : p53, dyskératose congénitale et anémie de Fanconi.

    Toufektchan, Eléonore / Jaber, Sara / Toledo, Franck

    Medecine sciences : M/S

    2017  Volume 33, Issue 1, Page(s) 95–98

    Title translation Dangerous liaisons: p53, dyskeratosis congenita and Fanconi anemia.
    MeSH term(s) Animals ; DNA Repair/genetics ; Dyskeratosis Congenita/complications ; Dyskeratosis Congenita/genetics ; Fanconi Anemia/complications ; Fanconi Anemia/genetics ; Genes, p53/physiology ; Humans ; Mice ; Mice, Knockout ; Telomere/metabolism ; Telomere Homeostasis/genetics ; Tumor Suppressor Protein p53/physiology
    Chemical Substances Tumor Suppressor Protein p53
    Language French
    Publishing date 2017-01
    Publishing country France
    Document type News
    ZDB-ID 632733-3
    ISSN 1958-5381 ; 0767-0974
    ISSN (online) 1958-5381
    ISSN 0767-0974
    DOI 10.1051/medsci/20173301018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top